Biogen Idec Inc., the world’s largest maker of medicines for multiple sclerosis, sued Bayer AG, Pfizer Inc., and Merck KGaA’s Serono unit for patent royalties on drugs similar to its Avonex treatment.
Biogen Idec claims the drugs Rebif promoted by Pfizer and Serono, Bayer’s Betaseron, and a version sold by Novartis AG as Extavia infringe a patent issued in September. The complaint was filed May 28 in federal court in Newark................... Read More - http://www.msrc.co.uk/index.cfm/fuseact ... ageid/1809